Norway
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 47.40 M
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
2 |
USD 27.43 M
|
Dec. 31, 2023 | USD 0.19 | -0.80% |
|
Norway |
|
3 |
USD 21.83 M
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
4 |
USD 14.40 M
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
5 |
USD 6.52 M
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
The Pharmaceuticals company in Norway with the highest Shareholders' Equity is Photocure ASA (Oslo Stock Exchange: PHO.OL) at USD 47.40 M.
The Pharmaceuticals company in Norway with the lowest Shareholders' Equity is Lifecare AS (Oslo Stock Exchange: LIFE.OL) at USD 6.52 M.
The top 10 Pharmaceuticals companies in Norway by Shareholders' Equity are Photocure ASA, Ultimovacs ASA, Navamedic ASA, Gentian Diagnostics ASA and Lifecare AS.
The bottom 10 Pharmaceuticals companies in Norway by Shareholders' Equity are Lifecare AS, Gentian Diagnostics ASA, Navamedic ASA, Ultimovacs ASA and Photocure ASA.